Canara HSBC Life Insurance is a prominent bank-led private life insurer in India, benefiting from the robust backing of its powerful promoters: Canara Bank (India’s fourth-largest public sector bank) and HSBC Insurance (a member of the globally reputable HSBC group). This formidable bancassurance partnership gives the company access to an extensive network of over 15,700 branches, which drives over 87% of its new business premium.

It recorded the third-highest individual Weighted Premium Income (WPI) growth among bank-led insurers between Fiscal 2022 and 2025 and steadily increasing Embedded Value, which reached ₹61.1 billion as of March 31, 2025. With a Solvency Ratio of 200.42% (as of June 30, 2025), the company is well-capitalized to pursue growth, leveraging its digital capabilities and comprehensive product suite to serve a customer base of over 10.5 million lives.

For the year/period ended (Rs. in Cr.)

For year/ period ended ( in Cr.)

*Market cap @upper band

• Promoter Strength & Brand: Established parentage (Canara Bank & HSBC) and a trusted brand amplify customer attraction and market credibility.
• Financial Performance & Value: Consistent and profitable financial performance drives long-term value creation for stakeholders, indicating sound strategy.
• Distribution and Products: A multi-channel, PAN-India distribution network is supported by a diversified, customer-centric product portfolio.
• Technology and Management: A technology-integrated platform uses automation and analytics for prudent risk management, led by an experienced management team.

The Company CANARA HSBC LIFE INSURANCE COMPANY LIMITED IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:

• To carry out the Offer for Sale of up to 237,500,000 Equity Shares of face value of ₹10 each by the Selling Shareholders
• Achieve the benefits of listing the Equity Shares on the Stock Exchanges.

At the upper band of IPO ₹ 106, the stock is valued at a high 86.18 P/E multiple. Hence, well-informed investors subscribe for medium to long term perspective.